Contact us for free information or to start a free case review.
There is no evidence to date that Zyprexa withdrawal symptoms are a significant source of concern regarding this atypical anti-psychotic prescription drug. Zyprexa was approved for use in the United States in 1996 to treat the adverse symptoms associated with schizophrenia and the manic symptoms of bipolar disorder. The only Zyprexa withdrawal symptom that is noticeable with discontinuation of this medication is the return of the adverse psychological symptoms this drug is used to treat.
Schizophrenia is a psychological condition which can cause a person to become delusional, hallucinate, suffer from confused thoughts, and display violent or aggressive behavior. Clinical trials have shown that Zyprexa can be successful in treating these symptoms. One such study revealed that schizophrenic patients taking Zyprexa for more than one year were significantly less likely to exhibit violent or aggressive behaviors. It is possible for these symptoms to resurface if a patient discontinues treatment and suffers from Zyprexa withdrawal.
Zyprexa withdrawal is more likely to be injurious to patients if they abruptly discontinue their treatment. For this reason, it is very important for patients taking Zyprexa to speak with their doctor before making any changes to their treatment. A doctor will be able to recommend a plan that will ensure patient safety and potentially mitigate any possible risk of a Zyprexa withdrawal.
While Zyprexa withdrawal is not a huge issue, there are serious side effects associated with this medication of which patients should be aware. Zyprexa use can cause significant weight gain in some patients, as well as other common side effects including: drowsiness, dry mouth, dizziness, weakness, low blood pressure, trembling, and body temperature regulation problems. There are also serious health problems that can be caused by Zyprexa including diabetes mellitus, ketoacidosis, pancreatitis, hyperglycemia, neuroleptic malignant syndrome, tardive dyskinesia, seizures, and coma. There are some drugs that can also interact with Zyprexa use.
Despite this laundry list of side effects, the US government has not chosen to request a Zyprexa withdrawal from the market from Eli Lilly, the makers of this drug. Zyprexa is the United States'' best selling atypical antipsychotic medication, which rakes in $2.6 billion dollars in annual revenue in the US alone.
On March 6, 2008, the State of Alaska provided its opening arguments in a lawsuit against the maker of the schizophrenia drug Zyprexa.
The lawsuit contends that the pharmaceutical giant Eli Lilly played down the diabetes and weight gain The maker of the popular antipsychotic drug Zyprexa is in talks to settle state and federal claims over the company’s marketing practices for more than $1 billion, potentially the... Strong new warnings were added to the label of the top-selling antipsychotic Zyprexa last week, alerting patients and physicians to the increased risk of high blood sugar and » Read More "Makers of Zyprexa may Settle Suit"
"High Blood Sugar and Weight Gain Risks"
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.